Browsing: ALS

NRG Therapeutics takes a first-in-human step toward disease-modifying treatments for ALS and Parkinson’s, targeting aging at cellular level. There are…

FDA greenlights early-stage trial of VectorY’s first-in-class therapy targeting the core biology driving most ALS cases. Netherlands-based biotech VectorY Therapeutics…

Credit: Westend61/Getty Images A new study from researchers at Northwestern University has described how the TDP-43 protein moves from its…

Motor neurons, especially larger ones, must work harder to prevent misfolded proteins from accumulating.Image credit:© iStock, peterschreiber.mediaAmyotrophic lateral sclerosis (ALS)…

Evidence of an autoimmune component to ALS neurodegeneration sheds new light on the causes of this as-yet incurable disease.Image credit:©…

Researchers at the La Jolla Institute for Immunology (LJI) and Columbia University Irving Medical Center have uncovered evidence that amyotrophic…